Navigation Links
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009
Date:4/29/2009

PALO ALTO, Calif., April 29 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today reported net earnings from continuing operations of $0.64 per diluted share in the second quarter of fiscal year 2009 versus net earnings from continuing operations of $0.57 per diluted share in the year-ago quarter. Including the discontinued ACCEL research instruments operation, net earnings per diluted share in the quarter were $0.54.

Compared to continuing operations in the year-ago quarter, second quarter revenues rose 7 percent to $554 million, net orders rose 2 percent to $524 million, and the backlog rose 12 percent to $1.9 billion.

"Net orders grew in our Oncology Systems and Security and Inspection Products businesses but fell in our X-Ray Products business," said Tim Guertin, president and CEO of Varian Medical Systems. "Revenues from continuing operations increased in all three businesses, and our gross margin improved by nearly three percentage points, contributing to higher earnings versus the year-ago quarter. However, we began to feel the effects of the global recession during the quarter which resulted in modest net orders growth. Currency fluctuations negatively impacted orders and revenue growth in the quarter."

The company ended the second quarter with $375 million in cash and cash equivalents and $43 million of debt. Days sales outstanding was 87 for the quarter, an improvement of three days versus the year-ago period and up four days from the preceding quarter. The company did not repurchase shares of its stock during the period.

Oncology Systems

Oncology Systems' revenues for the quarter totaled $445 million, up 6 percent from the second quarter of last fiscal year. This business recorded second-quarter net orders of $434 million, up 5 percent from the same pe
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Varian, Inc. Reports Second Quarter 2009 Results
2. Worlds largest DNA scan for autism uncovers new gene variant for disorder
3. MCG participating in national study to identify genetic variants in schizophrenia
4. Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago
5. Image-guided treatment helping women with tubo-ovarian abscesses avoid unnecessary surgery
6. Genetic variants predict recurrence of bladder cancer, patient survival
7. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
8. Chemo Combo Shows Promise Against Ovarian Cancer
9. Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
10. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, and X-Ray Tubes at the CMEF Show in Shenzhen, China
11. Gene Variant Tied to Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... D begins in the womb, expert says, , , TUESDAY, ... who drink lots of milk and have a high ... much lower risk of developing multiple sclerosis later in ... U.S. nurses whose mothers provided information about their experiences ... 16 years, and 199 of them developed multiple sclerosis ...
(Date:2/9/2010)... the Heart with "The Heart-Smart Diabetes ... 9 Show your love this ... the heart with the new cookbook "The Heart-Smart ... Canola Oil" by the American Diabetes Association (ADA) and ... love or give the cookbook as a gift, you ...
(Date:2/9/2010)... Reptiles are bred in captivity primarily for their skins, ... for their meat. A study shows that eating these ... the wisdom of eating this ,delicacy., , Parasites, bacteria ... heavy metals and residues of veterinary drugs- eating reptile ... the conclusion of a study published in the ...
(Date:2/9/2010)... study to date of secondhand smoke exposure among children ... Addiction . The study, carried out by researchers from ... exposure to household secondhand smoke among children aged 4-15 ... to find out if there were ways to predict ... private households, and whether those levels were changing over ...
(Date:2/9/2010)... results from a large-scale study of key antimalarial ... a high percentage of medicines circulating on national ... contribute to the growth of drug-resistant strains of ... of malaria. The findings, released today by the ... USAID-funded program implemented by the US Pharmacopeial Convention ...
Breaking Medicine News(10 mins):Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2Health News:Cook With Love This Valentine's Day With Heart-Smart Recipes 2Health News:Cook With Love This Valentine's Day With Heart-Smart Recipes 3Health News:Study carried out into biological risks of eating reptiles 2Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3
... likely to be deadly when tumor cells spread to the ... that may be able to predict a tumor’s growth pattern, ... the University of Michigan Comprehensive Cancer Center are studying a ... to leave their original location and enter nearby blood vessels.// ...
... factors for age-related macular degeneration, a sight-robbing disease mainly ... and more people worldwide are showing signs of age-related ... over 70 are diagnosed with the condition. While most ... percent to 8 percent have an advanced form, which ...
... to numerous health concerns. But a new study finds ... to link weight to athletic performance and appearance than ... see the importance of a healthy weight, instead viewing ... and self-esteem.,These results come //from an extensive set of ...
... reduction in blood pressure as the result of ... new study. ,To investigate the effect of aspirin ... Ramon C. Hermida, Ph.D., of Bioengineering and Chronobiology ... colleagues studied a group of 100 volunteers with ...
... a better treatment than the antiplatelet drug ticlopidine for ... research in this week’s issue of the Journal of ... and women who recently had strokes that were not ... of a blood vessel in the brain. Participants received ...
... if you let your children spend even a short amount of ... of this disease by a generous proportion., ,"Anytime you get a ... But get that burn before the age of 18, and your ... experiences sunburn or even sun damage caused by a tan, the ...
Other Medicine News:Health News:Night Time Aspirin Regimen Found to Reduce Blood Pressure 2Health News:Childhood Sunburn Can Lead to Skin Cancer Later 2
(Date:2/9/2010)... February 9 Debiopharm Group,(Debiopharm), ... with,a focus on the development of prescription ... the signature of an exclusive licence agreement ... of Debio 025,(alisporivir), a selective, first-in-class cyclophilin ... (HCV) effect. The product is currently in ...
(Date:2/8/2010)... FRANKLIN LAKES, N.J. , Feb. 8 /PRNewswire/ ... and Company), announced today the launch of BD Microtainer® ... new product is designed to improve the safety, accuracy ... in patients with veins that can be difficult to ... elderly. The new BD Microtainer MAP product is also ...
(Date:2/8/2010)... Sagent Pharmaceuticals, Inc., a privately held ... received FDA approval of labetalol hydrochloride (HCl) injection, ... product will be available in two vial sizes ... mg per 40 mL, multi-dose vials.  According to ... Americans have hypertension, or high blood pressure.  IMS ...
Breaking Medicine Technology:Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3BD Launches New Device Designed to Improve Safety, Accuracy and Turnaround Time of Blood Collection in Patients with Fragile Veins 2Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP 2Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP 3New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 1New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 2New and Updated Online Tutorials for ArrayExpress Allen Brain Atlas and CleanEx from OpenHelix 54389 3Cancer Mortality Rates Experience Steady Decline 54386 1Cancer Mortality Rates Experience Steady Decline 54386 2Cancer Mortality Rates Experience Steady Decline 54386 3Cancer Mortality Rates Experience Steady Decline 54386 4APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 1APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 54384 2
... May 31 Eli Lilly and Company announced today ... Lilly,s GEMZAR(R) (gemcitabine HCl for injection) to the current ... progression-free survival at three years for women with locally ... second most commonly diagnosed women,s cancer, and the second ...
... than double risk of cancer recurrence in tamoxifen treated ... drugs that reduce its effectiveness against breast cancerORLANDO, Fla., ... certain popular antidepressants frequently prescribed to women taking the ... of a breast cancer recurrence for those using both ...
Other Medicine Technology:Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 2Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 3Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 4Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 6New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 2New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 3New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 5
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Medicine Products: